CAR T-Cell Therapy Cost in India
The cost of CAR T-Cell Therapy in India typically ranges from $45,000 to $85,000, offering patients access to one of the most advanced cancer treatments at a significantly lower cost than in many Western countries. CAR T-Cell Therapy (Chimeric Antigen Receptor T-Cell Therapy) is a highly personalized immunotherapy that uses a patient’s own genetically modified T-cells to accurately identify and destroy cancer cells.
This breakthrough treatment has shown remarkable success in relapsed or refractory blood cancers, including leukemia, lymphoma, and multiple myeloma, especially in patients who have not responded to conventional therapies.
India has rapidly emerged as a leading destination for CAR T-Cell Therapy medical tourism due to its advanced cancer centers, experienced hematologists and oncologists, and access to globally approved CAR T products. Patients benefit from comprehensive evaluation, close monitoring during treatment, and structured post-therapy care. With strong clinical outcomes and affordable pricing, India offers a safe, effective, and accessible option for CAR T-Cell therapy abroad.
Estimated Cost of CAR-T Cell Therapy in India
Minimum Cost
$45000
Maximum Cost
$85000
Total Hospital Stays
25 days
Cost Range of CAR T-Cell Therapy in India
| Type of FDA Approved CAR T-Cell Therapy in India | Diagnosed | Cost in USD | ||
|---|---|---|---|---|
| Kymriah | B-Cell Acute Lymphoblastic Leukemia (ALL) vs. B-Cell Non-Hodgkin’s Lymphoma (NHL) | $65,000 – $85,000 | ||
| Yescarta |
| $65,000 – $85,000 | ||
| Tecartus | Mantle Cell Lymphoma, B-cell ALL | $65,000 – $85,000 | ||
| Breyanzi | B-cell NHL | $65,000 – $85,000 | ||
| Abecma | Multiple Myeloma | $45,000 – $65,000 | ||
| Carvykti | Multiple Myeloma | $45,000 – $65,000 |
Types of CAR T-Cell Therapy
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL)
Highly effective in children and young adults with relapsed or refractory B-cell ALL.
CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma (NHL)
Used for aggressive lymphomas such as Diffuse Large B-Cell Lymphoma (DLBCL) after failure of standard treatments.
CAR T-Cell Therapy for Multiple Myeloma
Targets BCMA antigen and has shown high response rates in advanced multiple myeloma.
How Much Does CAR T-Cell Therapy Cost in India?
For most international patients, the complete CAR T-cell therapy package, including cell collection, genetic modification, infusion, hospitalization, and monitoring, ranges between USD 45,000 and USD 85,000.
Compared to costs exceeding USD 400,000 in the USA, India offers CAR T-Cell Therapy at 70–80% lower cost without compromising safety or outcomes.
Cost Comparison: India vs Other Countries
| Country | Approx. Cost (USD) |
| India | 45,000 – 85,000 |
| Turkey | 120,000 – 180,000 |
| UAE | 250,000 – 350,000 |
| USA | 400,000 – 500,000 |
Transparent Pricing for Better Healing.
We believe that great care starts with trust. That’s why we ensure complete transparency in our treatment pricing—no surprises, no hidden fees, just honest and clear costs for the care you deserve.
Get a free cost estimate
What Is CAR T-Cell Therapy?
CAR T-Cell Therapy is an advanced form of cancer immunotherapy in which a patient’s own T-cells are genetically engineered to express special receptors (CARs) that recognize cancer cells. Once infused back into the body, these modified cells multiply and actively destroy cancer cells.
How the CAR T-Cell Therapy Process Works
Collection of patient’s T-cells (Leukapheresis)
Genetic modification of T-cells in laboratory
Expansion of CAR T-cells
Conditioning chemotherapy
CAR T-cell infusion
Intensive monitoring for side effects
The entire process is highly controlled and personalized for each patient.
Who Needs CAR T-Cell Therapy?
CAR T-Cell Therapy is recommended for patients with:
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia (ALL)
Diffuse Large B-Cell Lymphoma (DLBCL)
Mantle Cell Lymphoma (MCL)
Follicular Lymphoma
Multiple Myeloma
Failure of at least two prior treatment lines
Eligibility is determined through disease status, organ function, prior treatments, and overall fitness.
CAR-T Cell Therapy Cost in India – Inclusions
CAR T-cell production
Lab tests and pathology
Infusion and hospital care
Oncologist consultations
Airport pickup and drop
CAR-T Cell Therapy Cost in India – Exclusions
International & domestic travel
Hotel and accommodation outside hospital
Additional device calibration or follow-ups
Post-operative physiotherapy or psychiatric care
Management of complications or unrelated conditions
Diagnostic Tests Before CAR T-Cell Therapy
| Diagnostic Test | Approx. Cost (USD) |
| Blood Tests | 50 – 100 |
| CT / MRI | 150 – 250 |
| PET Scan | 400 – 600 |
| Biopsy & Histopathology | 150 – 250 |
| Cardiac & Pulmonary Assessment | 100 – 150 |
Recovery After CAR T-Cell Therapy
Hospital monitoring: 2–3 weeks
Watch for CRS & neurological symptoms
Gradual immune recovery
Long-term remission monitoring
Faster recovery than stem cell transplant
Why Choose India for CAR T-Cell Therapy?
India has emerged as a global leader in CAR-T Cell Therapy due to several key advantages:
Affordable treatment without compromising quality
Access to FDA-approved therapies and advanced labs
Highly experienced oncologists and haematologists
State-of-the-art hospitals in Delhi, Mumbai, Chennai, and Hyderabad
Multilingual support for international patients
Fast-track medical visa and coordinated travel assistance by HOSPISITY
Hospisity coordinates end-to-end CAR T-Cell Therapy, from evaluation to recovery.
Why Choose HOSPISITY?
Trusted Medical Travel Partner – End-to-end patient support
Access to Top Cancer Centres – Handpicked specialists in CAR-T Cell Therapy
Global Hospital Network – Leading hospitals in India and Turkey
Personalized Case Handling – Dedicated HRE (Hospisity Relationship Executive)
Free teleconsultation before arrival and post-treatment follow-up
Best Doctors For CAR T- Cell Therapy Treatment in India
Dr. Nitin Sood
Senior DirectorMedical Oncology & Bone Marrow Transplant
Medanta – The Medicity, Gurugram
Dr. Sanjeev Kr. Sharma
Director - Haemato-oncology and Bone Marrow Transplant
BLK-Max Super Speciality Hospital,Delhi
Dr. Rahul Bhargava
Principal Director & Chief - Hematology, Hemato Oncology & Bone Marrow Transplant
Fortis Memorial Research Institute,Gurugram
Dr. Gaurav Dixit
Associate Director, Haemato-Oncology & Bone Marrow Transplant,
Artemis Hospital,Gurugram
Best Hospitals For CAR T- Cell Therapy Treatment in India
FAQs –CAR-T Cell Therapy
Research is ongoing, but current approvals are primarily for blood cancers.
The most common are cytokine release syndrome (CRS), fever, fatigue, and neurological effects, which are manageable under expert care.
Hospital stay may last up to 25 days, with full recovery and observation extending up to 60 days post-treatment.
Some CAR T-cells persist as memory cells, potentially offering long-term immunity.
Yes. HOSPISITY offers complete assistance including visas, appointments, hospital coordination, and accommodation.
Top JCI Accredited Hospitals centers in Delhi, Mumbai, Chennai, Hyderabad, and Bangalore offer CAR-T Cell Therapy,
Top Doctors By Specialty
- Best Liver Transplant Doctors in India
- Best Cancer Doctors in India
- Best Cardiology Treatment Doctors in India
- Best Neurology Doctors in India
- Best Spine Surgery Doctors in India
- Best Orthopedic Treatment Doctors in India
- Best Urology Doctors in India
- Best ENT Doctors in India
- Best Kidney Transplant Doctors in India
- Best Bone Marrow Transplant Doctors in India
Top Hospitals By Specialty
- Best Organ Transplant Hospitals in India
- Best Cancer Hospitals in India
- Best Cardiology Treatment Hospitals in India
- Best Neurology Hospitals in India
- Best Spine Surgery Hospitals in India
- Best Orthopedic Treatment Hospitals in India
- Best Urology Hospitals in India
- Best ENT Hospitals in India
- Best Ophthalmology Hospitals in India
- Best Obesity Hospitals in India